Inhibitor Therapeutics (INTI) EBIT (2012 - 2026)
Inhibitor Therapeutics (INTI) reported EBIT of -$618,597 for Q2 2026, compared with -$695,773 a year earlier.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) EBIT (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inhibitor Therapeutics' EBIT came in at -$3.37 million; for FY2025, it came in at -$3.43 million.
- By year, EBIT came in at -$3.66 million in FY2024, -$3.4 million in FY2023, -$657,926 in FY2022 and -$325,395 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBIT since Q2 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$695,632 (Q1 2026), -$1.32 million (Q4 2025) and -$741,215 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | -618,597.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -618,597.00 |
| Mar 31, 2026 | -695,632.00 |
| Dec 31, 2025 | -1.32 Mn |
| Sep 30, 2025 | -741,215.00 |
| Jun 30, 2025 | -695,773.00 |
| Mar 31, 2025 | -674,551.00 |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | -813,196.00 |
| Jun 30, 2024 | -585,147.00 |
| Mar 31, 2024 | -774,817.00 |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -759,528.00 |
| Jun 30, 2023 | -742,461.00 |
| Mar 31, 2023 | -629,724.00 |
| Dec 31, 2022 | -423,635.00 |
| Sep 30, 2022 | -69,987.00 |
| Jun 30, 2022 | -70,804.00 |
| Mar 31, 2022 | -93,500.00 |
| Dec 31, 2021 | -28,759.00 |
| Sep 30, 2021 | -66,248.00 |
API Access
Inhibitor Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();